Could a simple phosphate IV ease severe pancreatitis?
NCT ID NCT07681050
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study investigates whether giving phosphate through an IV can reduce the severity of acute pancreatitis in adults. Researchers want to know if low phosphate levels make the disease worse and if replenishing it helps. Participants receive either standard care or IV phosphate during their hospital stay, with blood samples and follow-up assessments to track outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Sodium Phosphate or Potassium Phosphate (given intravenously)
What this could lead to
If it works, this could point toward a simple, low-cost treatment to reduce the severity of acute pancreatitis.
What could go wrong
This is a small, early-phase study (100 people) at one hospital. It is designed mainly to test feasibility and dosing, not yet to prove effectiveness. The treatment may not improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Indomethacin for Post-ERCP Pancreatitis Preventi NCT07661498
- EXPAND Study: Understanding Diabetes Heterogenei NCT07670871
- Risk Factors for Infected Pancreatic Necrosis | NCT03253861
- Acute Surgical Care Risk Factors & Outcomes (NCT05195697)
- Supraglottic Oxygenation During ERCP – NCT07637721
- Heparin for Pancreatitis Organ Failure Trial NCT07609771
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
Contact Email: •••••@•••••
Contact